BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 17409396)

  • 1. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
    Nicoli S; Ribatti D; Cotelli F; Presta M
    Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The zebrafish/tumor xenograft angiogenesis assay.
    Nicoli S; Presta M
    Nat Protoc; 2007; 2(11):2918-23. PubMed ID: 18007628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
    Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish embryo, a tool to study tumor angiogenesis.
    Tobia C; De Sena G; Presta M
    Int J Dev Biol; 2011; 55(4-5):505-9. PubMed ID: 21858773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol derivative, trans-3,5,4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation.
    Alex D; Leong EC; Zhang ZJ; Yan GT; Cheng SH; Leong CW; Li ZH; Lam KH; Chan SW; Lee SM
    J Cell Biochem; 2010 Feb; 109(2):339-46. PubMed ID: 20014068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of proton beam on blood vessel formation in early developing zebrafish (Danio rerio) embryos.
    Jang GH; Ha JH; Huh TL; Lee YM
    Arch Pharm Res; 2008 Jun; 31(6):779-85. PubMed ID: 18563361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.
    Keyes KA; Mann L; Sherman M; Galbreath E; Schirtzinger L; Ballard D; Chen YF; Iversen P; Teicher BA
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):133-40. PubMed ID: 14593497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.
    Polverino A; Coxon A; Starnes C; Diaz Z; DeMelfi T; Wang L; Bready J; Estrada J; Cattley R; Kaufman S; Chen D; Gan Y; Kumar G; Meyer J; Neervannan S; Alva G; Talvenheimo J; Montestruque S; Tasker A; Patel V; Radinsky R; Kendall R
    Cancer Res; 2006 Sep; 66(17):8715-21. PubMed ID: 16951187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered human tumor xenografts with functional human vascular networks.
    Alonso-Camino V; Santos-Valle P; Ispizua MC; Sanz L; Alvarez-Vallina L
    Microvasc Res; 2011 Jan; 81(1):18-25. PubMed ID: 20934439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
    Kimura Y; Sumiyoshi M; Baba K
    Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
    Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
    Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologically induced angiogenesis in transgenic zebrafish.
    Raghunath M; Sy Wong Y; Farooq M; Ge R
    Biochem Biophys Res Commun; 2009 Jan; 378(4):766-71. PubMed ID: 19068208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells.
    Li D; Li XP; Wang HX; Shen QY; Li XP; Wen L; Qin XJ; Jia QL; Kung HF; Peng Y
    Oncol Rep; 2012 Sep; 28(3):937-42. PubMed ID: 22711017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
    Hu-Lowe DD; Zou HY; Grazzini ML; Hallin ME; Wickman GR; Amundson K; Chen JH; Rewolinski DA; Yamazaki S; Wu EY; McTigue MA; Murray BW; Kania RS; O'Connor P; Shalinsky DR; Bender SL
    Clin Cancer Res; 2008 Nov; 14(22):7272-83. PubMed ID: 19010843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gicerin/Cd146 is involved in zebrafish cardiovascular development and tumor angiogenesis.
    So JH; Hong SK; Kim HT; Jung SH; Lee MS; Choi JH; Bae YK; Kudoh T; Kim JH; Kim CH
    Genes Cells; 2010 Nov; 15(11):1099-110. PubMed ID: 20977546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.